Advance Online
Advance Online

Shared Management for the Treatment of Psoriatic Disease

A look at the NPF Shared Management video series.

Psoriatic arthritis (PsA) affects about 1 in 3 people with psoriasis, and early recognition, diagnosis, and treatment can potentially prevent and/or limit irreversible joint damage.[1] However, research has shown that there is a high prevalence of undiagnosed PsA in patients with psoriasis. [2]

Recognizing the importance of clinicians staying current on diagnosing and managing PsA, the National Psoriasis Foundation and Evan Siegel, M.D., Elaine Husni, M.D., and Joseph F. Merola, M.D., held a Shared Management of Psoriatic Disease Roundtable. This roundtable was divided into 4 modules:

Module 1: Psoriatic Arthritis: Pathophysiology, Prevalence, Psychosocial Impact, and Care

  • Overview of PsA prevalence and presentation
  • Psoriasis/PsA as a systemic disease
  • Impact on the patient
  • ACR/NPF guidelines for treatment of psoriatic arthritis

Module 2: Comorbidities

  • Overview of comorbidities associated with psoriasis, including PsA
  • Informing patients about comorbidities; partnering with patients
  • Emphasis on screening recommendations and screening tools
  • Case example and discussion

Module 3: Shared Management

  • Collaborative care with a multidisciplinary approach – not just dermatology/rheumatology collaboration, but also working with GI, Cardiology, etc.
  • When to refer – particularly important for the primary care audience
  • Case example and discussion

Module 4: Case Discussions

  • Roundtable discussion on several real psoriasis and PsA cases

Due the importance of this topic, not only for health care providers but for patients who are at risk, this Roundtable is freely available as enduring, evidence-based video CME series. Each video is between 20-30 minutes and the entire series is accredited for 1.5 AMA PRA Category 1 CreditsTM.

Watch the Series

Watch. Learn. Claim.

Watch part 1



2: Villani AP, Rouzaud M, Sevrain M, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(2):242-248. doi:10.1016/j.jaad.2015.05.001

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logoTwill Care logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.